{
    "organizations": [],
    "uuid": "66e67f15586621520831f329f94ed731cae89ce9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ultragenyx-reports-q4-loss-per-sha/brief-ultragenyx-reports-q4-loss-per-share-1-89-idUSASB0C6ID",
    "ord_in_thread": 0,
    "title": "BRIEF-Ultragenyx Reports Q4 Loss Per Share $1.89",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Ultragenyx Pharmaceutical Inc:\n* ULTRAGENYX REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND CORPORATE UPDATE\n* Q4 LOSS PER SHARE $1.89 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-21T05:15:00.000+02:00",
    "crawled": "2018-02-21T21:07:19.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ultragenyx",
        "pharmaceutical",
        "inc",
        "ultragenyx",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "corporate",
        "update",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}